FDA Reviewing Study Linking Diflucan To Miscarriage In Pregnant Women
The agency said it is also reviewing additional data.
The FDA said the current label for Diflucan does not suggest an increased risk of problems during pregnancies or abnormalities in developing babies when women took a single 150-milligram dose to treat vaginal yeast infections. The agency said doses...
To view the full article, register now.